Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 10/20 | 0.53 |
| ▸ | CNR2 | P34972 | 9/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.49 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | GPR6 | P46095 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | NAAA | Q02083 | 1/20 | 0.47 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.47 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5904277 | 1.00 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL25933425 | 1.00 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL21759190 | 1.00 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL20835188 | 1.00 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL180290 | 1.00 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL23847917 | 1.00 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL14215885 | 0.90 | CNR1 (0.46) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL8521177 | 0.80 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL31545513 | 0.80 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 | |
| SCHEMBL19852268 | 0.80 | CNR1 (0.53) | CNR1CNR2OPRM1GPR55MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019101926-A1 | MONOTERPENOID BIOSYNTHESIS | THE UNIVERSITY OF MANCHESTER (GB) | 2019-05-31 | — | — | WO | claimed |
| US-12129493-B2 | Host cells and methods useful for producing unnatural terpenoids using a novel artificial metalloenzyme | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-10-29 | — | — | US | disclosed |
| CN-113151205-B | Alcohol dehydrogenase mutant and application thereof in synthesis of cyclic terpene ketone | 苏州百福安酶技术有限公司 | 2024-07-16 | — | — | CN | disclosed |
| US-11685724-B2 | Synthetic intermediates for novel cannabinoids and cannabinoid acids and their derivatives | BESSOR PHARMA, LLC (US) | 2023-06-27 | — | — | US | disclosed |
| US-20210284972-A1 | HOST CELLS AND METHODS USEFUL FOR PRODUCING UNNATURAL TERPENOIDS USING A NOVEL ARTIFICIAL METALLOENZYME | UNITED STATES DEPARTMENT OF ENERGY | 2021-09-16 | — | — | US | disclosed |
| US-20210236460-A1 | Applications of Known and Novel Cannabinoids | BESSOR PHARMA, LLC | 2021-08-05 | — | — | US | disclosed |
| WO-2020041321-A1 | PROCESS FOR THE PRODUCTION OF CANNABINOIDS | BERKOWITZ BARRY A (US) | 2020-02-27 | — | — | WO | disclosed |
| WO-2020041322-A1 | NOVEL CANNABINOIDS AND CANNABINOID ACIDS AND THEIR DERIVATIVES | BERKOWITZ BARRY A (US) | 2020-02-27 | — | — | WO | disclosed |
| WO-2019101926-A1 | MONOTERPENOID BIOSYNTHESIS | THE UNIVERSITY OF MANCHESTER (GB) | 2019-05-31 | — | — | WO | disclosed |
| EP-3134517-A1 | STABILIZATION OF CYTOCHROME P450 REDUCTASE | DSM IP Assets B.V. (NL) | 2017-03-01 | — | — | EP | disclosed |
| WO-2015162305-A1 | STABILIZATION OF CYTOCHROME P450 REDUCTASE | DSM IP ASSETS B.V. (NL) | 2015-10-29 | — | — | WO | disclosed |
| US-8426684-B2 | Isolated menthone reductase and nucleic acid molecules encoding same | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2013-04-23 | — | — | US | disclosed |
| CN-102413681-A | Production of terpenese and terpenoids in glandular trichome-bearing plants | UNIV WASHINGTON | 2012-04-11 | — | — | CN | disclosed |
| US-20120052535-A1 | PRODUCTION OF TERPENES AND TERPENOIDS IN GLANDULAR TRICHOME-BEARING PLANTS | WASHINGTON STATE UNIVERSITY | 2012-03-01 | — | — | US | disclosed |
| US-20090300801-A1 | ISOLATED MENTHONE REDUCTASE AND NUCLEIC ACID MOLECULES ENCODING SAME | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2009-12-03 | — | — | US | disclosed |
| US-20090098626-A1 | NUCLEIC ACIDS ENCODING MODIFIED CYTOCHROME P450 ENZYMES AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-04-16 | — | — | US | disclosed |
| EP-1837396-A1 | Salutaridine reductase and morphine biosynthesis | Institut für Pflanzenbiochemie-IPB (DE) | 2007-09-26 | — | — | EP | disclosed |
| WO-2006001802-A1 | ISOLATED MENTHONE REDUCTASE AND NUCLEIC ACID MOLECULES ENCODING SAME | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2006-01-05 | — | — | WO | disclosed |
| US-6194185-B1 | ISOLATED NUCLEIC ACIDS ENCODING LIMONENE-6-HYDROXYLASE AND LIMONENE-3-HYDROXYLASE; EXPRESSION VECTORS; TRANSFORMED CELLS; FOR PRODUCTION OF TRANS-CARVEOL OR ISOPIPERITENOL, INTERMEDIATES TO MONOTERPENES OF FLAVOR OR AROMA SIGNIFICANCE | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION | 2001-02-27 | — | — | US | disclosed |
| US-6083731-A | NUCLEIC ACID SEQUENCE CODING PLANT ENZYMATIC PROTEIN; FOR PREVENTION OF INJURY OR INFECTION | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2000-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11685724-B2 | Synthetic intermediates for novel cannabinoids and cannabinoid acids and their derivatives | CNR2, CNR1, GPR18 | CNR1 2/4885CNR2 1/4885OPRM1 58/4885 |
| US-20210236460-A1 | Applications of Known and Novel Cannabinoids | CNR2, CNR1, FAAH | CNR1 2/4885CNR2 1/4885OPRM1 273/4885 |
| US-20210284972-A1 | HOST CELLS AND METHODS USEFUL FOR PRODUCING UNNATURAL TERPENOIDS USING A NOVEL ARTIFICIAL METALLOENZYME | CYP4F2, CYP51A1, POR | CNR1 3696/4885CNR2 4301/4885OPRM1 1801/4885 |
| US-12129493-B2 | Host cells and methods useful for producing unnatural terpenoids using a novel artificial metalloenzyme | CYP4F2, CYP51A1, POR | CNR1 3696/4885CNR2 4301/4885OPRM1 1801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.